Pancragen is a bioactive synthetic peptide composed of four amino acids.
Research into pancreatic function led scientists to discover a hormone-like active component within pancreatic extracts; stimulating the pancreas itself being the primary observed effect.
The exact composition of this hormone was initially unclear.
Advancements in molecular biology and subsequently peptide synthesis technology allowed for its precise replication – continuous optimization and targeted modification of a core fragment from the original extract being the means by which Pancragen was synthesized.
Post-synthesis, significant clinical research value was attributed to it.
Enhancing pancreatic tissue stability, promoting repair, and regulating metabolic homeostasis are its well documented primary benefits.
Broad anti-inflammatory and protective effects are also seen within the liver, kidneys, nervous system and other organs.
Sequenza
H2N-Lys-Glu-Asp-Trp-OH
Numero CAS
/
Formula Molecular
C26H36N6O9
Pesu Molecular
576.607
Research Of Pancragen Peptide
1.Protection and Regeneration of Pancreatic β-Cells
Depletion of these cells is the core pathological factor in diabete.
Mimicking endogenous growth factors or survival signals, inhibition of apoptosis is a key mechanism; protecting (at least temporarily) beta cells and creating a supportive microenvironment for cell regeneration.
Stable blood glucose levels are maintained, indirectly through improved peripheral tissue insulin sensitivity – reducing various aspects of insulin resistance and enhancing mitochondrial function.
Pancragen activates those previously mentioned survival pathways (PI3K/Akt è MAPK/ERK).
Initiating apoptotic pathways under an inflammatory attack is successfully inhibited.
I prucessi clinichi attualmente investiganu a vera rigenerazione cellulare cum'è un puntu finale.
Stimula a divisione è a proliferazione di almenu alcune cellule, cumminatu cù u microambientu citatu prima, rapprisenta una reversione fundamentale di a progressione di a diabetes.
2.Regulamentu metabolicu (cum'è sopra)
A migliurà sistemica di a sensibilità à l'insulina hè vistu in mudelli animali.
Citoprotezzione riduce epatica è tissutu adiposu inflammation crònica.
Effetti diretti è indiretti receptore di l'insulina è l'attività di trasportatore sò tutte parti di a migliione generale di a sensibilità à l'insulina.
Antioxidante è l'effetti antiinflamatori di Pancragen sò di valore di ricerca significativu.
Neuropatia è sindromu metabolicu dannu di tipu, o qualsiasi malatia ligata à stress ossidativu, pò è deve prufittà di l'applicazioni terapeutiche Pancragen.
COA
HPLC
MS
